Nevro Corp (NVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 102,760 | 93,205 | 102,330 | 88,610 | 109,731 |
| Cost of Goods | 33,628 | 28,575 | 32,344 | 26,316 | 31,703 |
| Gross Profit | 69,132 | 64,630 | 69,986 | 62,294 | 78,028 |
| Operating Expenses | 95,975 | 111,649 | 86,093 | 85,122 | 79,606 |
| Operating Income | -26,215 | -46,444 | -15,763 | -22,512 | -875 |
| Interest Expense | 3,810 | 3,688 | 5,704 | 6,547 | 6,495 |
| Other Income | -187 | 129 | 75 | -160 | 551 |
| Pre-tax Income | -30,212 | -50,003 | -21,392 | -29,219 | -6,819 |
| Income Tax | -78 | 72 | 198 | 342 | 310 |
| Net Income Continuous | -30,134 | -50,075 | -21,590 | -29,561 | -7,129 |
| Net Income | $-30,134 | $-50,075 | $-21,590 | $-29,561 | $-7,129 |
| EPS Basic Total Ops | -0.86 | -1.44 | -0.62 | -0.85 | -0.19 |
| EPS Basic Continuous Ops | -0.86 | -1.44 | -0.62 | -0.85 | -0.19 |
| EPS Diluted Total Ops | -0.86 | -1.44 | -0.62 | -0.85 | -0.19 |
| EPS Diluted Continuous Ops | -0.86 | -1.44 | -0.62 | -0.85 | -0.19 |
| EBITDA(a) | $-20,807 | $-41,568 | $-9,505 | $-15,603 | $5,762 |